Literature DB >> 1448110

Structural and functional analysis of the insulin-like growth factor I receptor gene promoter.

H Werner1, M A Bach, B Stannard, C T Roberts, D LeRoith.   

Abstract

The insulin-like growth factor I receptor (IGF-I-R) gene is expressed in most body tissues. The levels of IGF-I-R mRNA, however, are regulated by a number of physiological conditions (development, differentiation, and hormonal milieu) as well as in certain pathological states (diabetes and tumors). To understand the molecular mechanisms which control the transcription of the IGF-I-R gene, we have cloned the promoter of the rat receptor gene and have characterized its activity by transient expression assays. Different fragments of the 5'-flanking region (subcloned upstream of a luciferase reporter gene) were transfected into buffalo rat liver 3A cells (a cell line with a low number of IGF-I binding sites) and Chinese hamster ovary cells (a cell line with a higher number of cell-surface receptors). In both cell lines, most of the promoter activity was located in the proximal 416 base pairs of 5'-flanking region. However, further dissection of this proximal fragment revealed a cell type-specific pattern of promoter activity. Thus, in buffalo rat liver 3A cells, subfragments of this region each contributed to total activity, suggesting that contiguous cis-elements can act together to activate transcription. In Chinese hamster ovary cells, on the other hand, subfragments of the proximal promoter region partially substituted for the proximal 416 base pairs of 5'-flanking region. Coexpression studies using an IGF-I-R promoter reporter construct together with an Sp1 expression vector (under the control of an ADH promoter) were performed in SL2 cells, a Drosophila cell line which lacks endogenous Sp1. The results obtained showed that Sp1 can trans-activate the IGF-I-R promoter in vivo. Transient transfection assays were complemented with gel-retardation assays and DNase I footprinting experiments, which showed that transcription factor Sp1 is potentially an important regulator of IGF-I-R gene expression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1448110     DOI: 10.1210/mend.6.10.1448110

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  22 in total

1.  Angiotensin II stimulates transcription of insulin-like growth factor I receptor in vascular smooth muscle cells: role of nuclear factor-kappaB.

Authors:  Yewei Ma; Liping Zhang; Tao Peng; Jizhong Cheng; Shilpa Taneja; Jiqiang Zhang; Patrice Delafontaine; Jie Du
Journal:  Endocrinology       Date:  2005-12-01       Impact factor: 4.736

2.  The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal.

Authors:  M Prisco; A Hongo; M G Rizzo; A Sacchi; R Baserga
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

3.  Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.

Authors:  H Werner; C T Roberts; F J Rauscher; D LeRoith
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

Review 4.  Insulin-like growth factors: actions on the skeleton.

Authors:  Shoshana Yakar; Haim Werner; Clifford J Rosen
Journal:  J Mol Endocrinol       Date:  2018-04-06       Impact factor: 5.098

5.  Function of insulin-like growth factor 1 receptor in cancer resistance to chemotherapy.

Authors:  Jingsheng Yuan; Zhijie Yin; Kaixiong Tao; Guobing Wang; Jinbo Gao
Journal:  Oncol Lett       Date:  2017-10-26       Impact factor: 2.967

6.  Insulin-like growth factor-I receptor (IGF-IR) translocates to nucleus and autoregulates IGF-IR gene expression in breast cancer cells.

Authors:  Rive Sarfstein; Metsada Pasmanik-Chor; Adva Yeheskel; Liat Edry; Noam Shomron; Naama Warman; Efrat Wertheimer; Sharon Maor; Lea Shochat; Haim Werner
Journal:  J Biol Chem       Date:  2011-11-29       Impact factor: 5.157

7.  Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene.

Authors:  H Werner; E Karnieli; F J Rauscher; D LeRoith
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-06       Impact factor: 11.205

8.  Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product.

Authors:  H Werner; G G Re; I A Drummond; V P Sukhatme; F J Rauscher; D A Sens; A J Garvin; D LeRoith; C T Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

9.  Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression.

Authors:  H Werner; Z Shen-Orr; F J Rauscher; J F Morris; C T Roberts; D LeRoith
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

10.  The regulation of MS-KIF18A expression and cross talk with estrogen receptor.

Authors:  Margalit Zusev; Dafna Benayahu
Journal:  PLoS One       Date:  2009-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.